OBJECTIVE: This study aimed at evaluating linear discriminant analysis (LDA) and support vector machine (SVM) classifiers for estimating final Gleason score preoperatively using multiparametric magnetic resonance imaging (mp-MRI) and clinical parameters.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
MATERIALS AND METHODS: Thirty-three patients who underwent mp-MRI on a 3T clinical MR scanner and radical prostatectomy were enrolled in this study. The input features for classifiers were age, the presence of a palpable prostate abnormality, prostate specific antigen (PSA) level, index lesion size, and Likert scales of T2 weighted MRI (T2w-MRI), diffusion weighted MRI (DW-MRI), and dynamic contrast enhanced MRI (DCE-MRI) estimated by an experienced radiologist. SVM based recursive feature elimination (SVM-RFE) was used for eliminating features. Principal component analysis (PCA) was applied for data uncorrelation.
RESULTS: Using a standard PCA before final Gleason score classification resulted in mean sensitivities of 51.19% and 64.37% and mean specificities of 72.71% and 39.90% for LDA and SVM, respectively. Using a Gaussian kernel PCA resulted in mean sensitivities of 86.51% and 87.88% and mean specificities of 63.99% and 56.83% for LDA and SVM, respectively.
CONCLUSION: SVM classifier resulted in a slightly higher sensitivity but a lower specificity than LDA method for final Gleason score prediction for prostate cancer for this limited patient population.
Citak-Er F, Vural M, Acar O, Esen T, Onay A, Ozturk-Isik E. Are you the author?
Department of Genetics and Bioengineering, Yeditepe University, İnönü Mah., Kayışdağı Cad, 26 Ağustos Yerleşimi, Ataşehir, 34755 Istanbul, Turkey; Department of Radiology, VKF American Hospital, 34365 Istanbul, Turkey; Department of Urology, VKF American Hospital, 34365 Istanbul, Turkey; School of Medicine, Koç University, 34450 Istanbul, Turkey; Biomedical Engineering Institute, Boğaziçi University, Rasathane Cad, Kandilli Campus, Kandilli Mah., 34684 Istanbul, Turkey.
Reference: Biomed Res Int. 2014;2014:690787.